## CPB: The Campbell's Company - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 -5.3% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($27.94)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bearish (Bullish: 0, Bearish: 1)

**1. ‘Sh-t for Poor People’: Campbell Soup VP Caught Spewing Racial Views About Co-workers in Voice Recording That’s Prompted Boycott, Piping-Hot Lawsuit**
- Source: Atlanta Black Star | 20251203T172144 | Bearish | Relevance: 100%
- A Campbell Soup Company executive, Martin Bally, is facing a lawsuit after a whistleblower employee, Robert Garza, secretly recorded him making disparaging comments about the company's products, customers, and Indian colleagues. Garza, a security analyst, claims he was fired shortly after reporting Bally's remarks to management. The lawsuit accuses Campbell Soup Company of maintaining a racially hostile work environment and retaliating against Garza, prompting public outcry and a boycott threat against the company.

**2. Macom Technology Solutions stock hits all-time high at 179.42 USD**
- Source: Investing.com | 20251203T080957 | Somewhat-Bearish | Relevance: 59%
- Macom Technology Solutions (MTSI) stock reached an all-time high of $179.42, reflecting robust market performance with significant year-to-date and six-month gains. Despite not being profitable in the last twelve months, analysts expect profitability in FY2026, with a projected EPS of $4.28. The company recently reported strong Q4 2025 earnings, leading to increased price targets from Needham and Truist Securities.

**3. HORMEL FOODS REPORTS FOURTH QUARTER AND FULL-YEAR FISCAL 2025 RESULTS**
- Source: KWKT - FOX 44 | 20251204T110847 | Neutral | Relevance: 59%
- Hormel Foods Corporation has reported its fourth-quarter and full-year fiscal 2025 results, with net sales reaching $12.1 billion for the full year, a 1.6% increase. Despite top-line growth driven by brand relevance, profitability was challenged by input cost inflation and non-cash impairment charges. The company projects net sales of $12.2 billion to $12.5 billion for fiscal 2026, anticipating improved earnings performance and continued dividend increases.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | UBS | $28 | $30 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | UBS | main | Sell |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 13 ($0.00M) |
| Sells | 9 ($1.41M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 34.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Blackrock Inc.: 8.5% (+6.3%)
- Vanguard Group Inc: 7.9% (-2.2%)
- State Street Corpora: 3.7% (-7.1%)
- Invesco Ltd.: 2.7% (+42.6%)
- Beutel, Goodman & Co: 2.3% (-11.6%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-1.6% 5d) with bearish MACD, trend may be turning.
2. High short interest (18.8%, 3.9 days to cover): squeeze risk or crowded bearish bet.
3. Long-term trend broken: trading 13.3% below SMA200.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.69 indicates undervaluation relative to growth. Analyst sentiment negative (1 target cuts vs 0 raises). Insider selling cluster ($1.4M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $8.4B |
| Beta | -0.06 |
| 52W Range | $27.64 - $43.85 |
| Short Interest | 18.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.69 |
| Forward P/E | 11.2 |
| Current P/E | 12.1 |
| YoY Growth | 7.8% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from -3.7% to -5.3% (-1.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 8.3pp (needs >3.0% for momentum thesis). Underperforming sector by 4.3pp, stock-specific weakness. Below SMA200 (0.87x), long-term trend not supportive. OFD pattern: -MLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -5.34% (CS: 4) | Weak |
| RSI_14 | 37.1 | Neutral |
| MACD Histogram | -0.13 | Bearish |
| vs SMA20 | 0.958x | Below |
| vs SMA50 | 0.954x | Below |
| vs SMA200 | 0.867x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $29.36
- **Stop Loss:** $27.94 (4.8% risk)
- **Target:** $30.78 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 352
- **Position Value:** $10,334.72
- **Portfolio %:** 10.33%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.73 | $0.77 | +5.0% |
| 2025Q3 | $0.57 | $0.62 | +9.0% |
| 2025Q2 | $0.66 | $0.73 | +11.4% |
| 2025Q1 | $0.72 | $0.74 | +2.3% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*